Gerhard Kelter

Title: Gerhard Kelter: Innovator in Cancer Treatment

Introduction

Gerhard Kelter is a notable inventor based in Ehrenkirchen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. His innovative work has led to the creation of a patent that holds promise for improving therapeutic options for patients.

Latest Patents

Kelter's most recent patent focuses on macrocyclic lactone derivatives for the treatment of cancer. The invention provides compounds represented by a specific formula, which includes various stereoisomeric and tautomeric forms, as well as their pharmaceutically acceptable salts, solvates, polymorphs, and prodrugs. This patent outlines processes for manufacturing these compounds and pharmaceutical compositions containing them. The compounds are designed to be effective in treating cancer, offering a method of treatment by administering a therapeutically effective amount to mammals in need.

Career Highlights

Throughout his career, Gerhard Kelter has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Piramal Enterprises Limited and Oncotest GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Kelter has collaborated with several professionals in his field, including Prabhu Dutt Mishra and Shafee Mohammed Abdul. These collaborations have likely enhanced his research and development efforts, leading to advancements in cancer treatment.

Conclusion

Gerhard Kelter's contributions to the field of cancer treatment through his innovative patents and collaborations highlight his commitment to improving healthcare. His work continues to inspire advancements in pharmaceutical research and development.